New Wave Wealth Advisors’s Ascendis Pharma A/S ASND Stock Holding History

New Wave Wealth Advisors’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.28M	Buy	4,814 +1,283	+36%	+$300K	0.35%	63
2026 Q1	$808K	Buy	3,531 +1,013	+40%	+$227K	0.28%	67
2025 Q4	$537K	Buy	2,518 +89	+4%	+$18.4K	0.2%	85
2025 Q3	$483K	Buy	2,429 +1,043	+75%	+$195K	0.19%	85
2025 Q2	$239K	Sell	1,386 -40	-3%	-$6.51K	0.1%	117
2025 Q1	$222K	Buy	+1,426	New	+$204K	0.1%	122

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

New Wave Wealth Advisors's ASND Position: Q2 2026 in Review

New Wave Wealth Advisors increased its Ascendis Pharma A/S (ASND) stake by 36% in Q2 2026, buying an estimated $300K and bringing the position to 4,814 shares worth $1.28M. The position accounts for 0.35% of the portfolio, ranked #63.

New Wave Wealth Advisors first reported a position in ASND in Q1 2025 and has held it in 6 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

New Wave Wealth Advisors held 4,814 shares of Ascendis Pharma A/S worth $1.28M as of Q2 2026.
New Wave Wealth Advisors bought 1,283 Ascendis Pharma A/S shares in Q2 2026, an estimated $300K.
Ascendis Pharma A/S made up 0.35% of New Wave Wealth Advisors's portfolio in Q2 2026, its #63 holding.
New Wave Wealth Advisors first reported a position in Ascendis Pharma A/S in Q1 2025 and has held it in 6 quarters since.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on New Wave Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.